ResearcherShizuoka General HospitalNo recent work listed

Ryoichi Matsunuma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9930-8747; OpenAlex author ID A5070865011. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ovarian cancer syndrome. Last author DOI 10.1093/omcr/omac124 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michiko Tsuneizumi · 1 shared paper, 2022 · strength 0.19
- Paper Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ova… DOI 10.1093/omcr/omac124 ↗
Shuzo Terada · 1 shared paper, 2022 · strength 0.19
- Paper Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ova… DOI 10.1093/omcr/omac124 ↗
Takeshi Usui · 1 shared paper, 2022 · strength 0.19
- Paper Long-term response to olaparib in a patient with metastatic pancreatic cancer associated with hereditary breast and ova… DOI 10.1093/omcr/omac124 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.